These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16899071)

  • 1. Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE.
    Wang C; Gold BG; Kaler LJ; Yu X; Afentoulis ME; Burrows GG; Vandenbark AA; Bourdette DN; Offner H
    J Neurochem; 2006 Sep; 98(6):1817-27. PubMed ID: 16899071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury.
    Offner H; Subramanian S; Wang C; Afentoulis M; Vandenbark AA; Huan J; Burrows GG
    J Immunol; 2005 Sep; 175(6):4103-11. PubMed ID: 16148160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
    Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
    J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
    Adamus G; Brown L; Andrew S; Meza-Romero R; Burrows GG; Vandenbark AA
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):406-12. PubMed ID: 22167100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
    Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S
    Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
    Sinha S; Miller L; Subramanian S; McCarty OJ; Proctor T; Meza-Romero R; Huan J; Burrows GG; Vandenbark AA; Offner H
    J Neuroimmunol; 2010 Aug; 225(1-2):52-61. PubMed ID: 20546940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D; Pham-Dinh D; Reynolds R
    Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional ultra-structures of myelin and the axons in the spinal cord: application of SEM with the osmium maceration method to the central nervous system in two mouse models.
    Nomura T; Bando Y; Bochimoto H; Koga D; Watanabe T; Yoshida S
    Neurosci Res; 2013 Mar; 75(3):190-7. PubMed ID: 23403366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS.
    Sinha S; Subramanian S; Proctor TM; Kaler LJ; Grafe M; Dahan R; Huan J; Vandenbark AA; Burrows GG; Offner H
    J Neurosci; 2007 Nov; 27(46):12531-9. PubMed ID: 18003831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.
    Mokhtarian F; Safavi F; Sarafraz-Yazdi E
    Brain Res; 2012 Dec; 1488():92-103. PubMed ID: 23031637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
    Ji X; Liu H; An C; Wang Y; Zhao H; Zhang Q; Li M; Qi F; Chen Z; Wang X; Wang L
    J Ethnopharmacol; 2016 Jul; 187():123-33. PubMed ID: 27106785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
    Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
    Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.